Learn more

CHUNG HUN TAEG

Overview
  • Total Patents
    14
About

CHUNG HUN TAEG has a total of 14 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Republic of Korea and Australia. Its main competitors in its focus markets pharmaceuticals, machines and organic fine chemistry are CHRONORX LLC, BIOGENESIS S A and PARNELL PHARMACEUTICALS INC.

Patent filings in countries

World map showing CHUNG HUN TAEGs patent filings in countries
# Country Total Patents
#1 Republic of Korea 13
#2 Australia 1

Patent filings per year

Chart showing CHUNG HUN TAEGs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chung Hun Taeg 12
#2 Jang Seon Il 7
#3 Pae Hyun Ock 6
#4 Oh Hyeon Cheol 5
#5 Bae Hyeon Ok 4
#6 Kwon Tae Oh 4
#7 Kim Youn Chul 3
#8 Kim Hyeong Jin 2
#9 Kim Yong Jun 2
#10 Chae Gyu Yun 2

Latest patents

Publication Filing date Title
KR20080019787A Pharmaceutical composition containing demethoxycurcumin to prevent restenosis
KR20040110119A Composition for curing cancer containing the extract of Jipaesan
KR20040103984A Anti-inflammatory composition containing the extracts of bojungikgitang or kagam-bojungikgitang
KR20040011777A Natural herbicidal substance isolated from Erigeron annuus L. and composition containing thereof
KR20030059643A Acetylenes from the Root of Acanthopanax senticosus and apoptosis-inducing composition containing the same
KR20030059644A (3R,6R)-4-methyl-6-(1-methylethyl)-3-phenylmethyl-1,4-perhydrooxazine-2,5-dione from the Fruiting Bodies of Isaria japonica and apoptosis-inducing composition containing the same
KR20030046796A A antiinflammatory compoisition containing catalposide isolated from stem bark of Catalpa ovata
KR20030016087A Anticancer composition containing 4-acetyl-12,13-epoxyl-9-trichothecene-3,15-diol isolated from the fruiting bodies of Isaria japonica YASUDA
KR20020045288A Immunopotentiating composition containing the extract of Rhodiola root
KR20020045287A Composition for treating leukemias containing water-soluble chitosan oligomer
KR20020045289A Immunopotentiating composition containing water-soluble chitosan oligomer and interferon-gamma
KR20010063258A Pharmaceutical composition containing nitric oxide(NO) or nitric oxide donor to treat autoimmune disease
KR20010054745A Pharmaceutical composition containing scopoletin for treating inflammation